Connable Office Inc’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,471
Closed -$883K 249
2025
Q4
$883K Hold
35,471
0.08% 99
2025
Q3
$904K Buy
35,471
+1,050
+3% +$25.9K 0.08% 99
2025
Q2
$834K Buy
34,421
+4,324
+14% +$101K 0.08% 102
2025
Q1
$763K Hold
30,097
0.08% 105
2024
Q4
$798K Hold
30,097
0.08% 105
2024
Q3
$871K Sell
30,097
-14,465
-32% -$422K 0.09% 106
2024
Q2
$1.25M Buy
+44,562
New +$1.23M 0.13% 86
2017
Q3
Sell
-49,249
Closed -$1.57M 178
2017
Q2
$1.57M Sell
49,249
-869
-2% -$27.4K 0.34% 61
2017
Q1
$1.63M Sell
50,118
-3,504
-7% -$110K 0.37% 62
2016
Q4
$1.65M Sell
53,622
-28,156
-34% -$860K 0.38% 64
2016
Q3
$2.63M Buy
81,778
+444
+0.5% +$14.8K 0.63% 41
2016
Q2
$2.72M Hold
81,334
0.76% 37
2016
Q1
$2.29M Buy
+81,334
New +$2.32M 0.63% 46
2015
Q3
Sell
-8,439
Closed -$268K 222
2015
Q2
$268K Hold
8,439
0.07% 153
2015
Q1
$279K Hold
8,439
0.07% 142
2014
Q4
$249K Hold
8,439
0.07% 155
2014
Q3
$237K Hold
8,439
0.06% 162
2014
Q2
$238K Sell
8,439
-3,619
-30% -$103K 0.06% 170
2014
Q1
$367K Hold
12,058
0.1% 120
2013
Q4
$350K Sell
12,058
-3,668
-23% -$107K 0.09% 127
2013
Q3
$429K Hold
15,726
0.12% 114
2013
Q2
$418K Buy
+15,726
New +$435K 0.12% 117

Other funds holding PFE

Connable Office Inc's PFE Position: Q1 2026 in Review

Connable Office Inc sold out of Pfizer (PFE) in Q1 2026, closing a stake of 35,471 shares — an estimated $883K sold.

Connable Office Inc first reported a position in PFE in Q2 2013 and held it in 22 quarters. The position peaked at $2.72M in Q2 2016. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Connable Office Inc reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Connable Office Inc sold 35,471 Pfizer shares in Q1 2026, an estimated $883K.
  • Connable Office Inc first reported a position in Pfizer in Q2 2013 and held it in 22 quarters.
  • Connable Office Inc's Pfizer position peaked at $2.72M in Q2 2016.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Connable Office Inc's 13F filing for Q1 2026, filed 29 Apr 2026.